Glassman Wealth Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-55
Closed -$1.72K 217
2023
Q4
$1.72K Hold
55
﹤0.01% 1392
2023
Q3
$1.15K Hold
55
﹤0.01% 1512
2023
Q2
$1.32K Hold
55
﹤0.01% 1367
2023
Q1
$1.04K Hold
55
﹤0.01% 1420
2022
Q4
$876 Sell
55
-25
-31% -$398 ﹤0.01% 1459
2022
Q3
$1K Sell
80
-6
-7% -$75 ﹤0.01% 1303
2022
Q2
$1K Sell
86
-135
-61% -$1.57K ﹤0.01% 1324
2022
Q1
$5K Buy
221
+28
+15% +$633 ﹤0.01% 983
2021
Q4
$5K Buy
193
+92
+91% +$2.38K ﹤0.01% 961
2021
Q3
$2K Buy
101
+35
+53% +$693 ﹤0.01% 1124
2021
Q2
$2K Sell
66
-258
-80% -$7.82K ﹤0.01% 1101
2021
Q1
$8K Buy
324
+62
+24% +$1.53K ﹤0.01% 755
2020
Q4
$14K Buy
262
+197
+303% +$10.5K ﹤0.01% 618
2020
Q3
$3K Hold
65
﹤0.01% 873
2020
Q2
$3K Hold
65
﹤0.01% 718
2020
Q1
$3K Buy
65
+6
+10% +$277 ﹤0.01% 583
2019
Q4
$3K Buy
59
+4
+7% +$203 ﹤0.01% 648
2019
Q3
$2K Sell
55
-8
-13% -$291 ﹤0.01% 660
2019
Q2
$2K Sell
63
-14,992
-100% -$476K ﹤0.01% 684
2019
Q1
$404K Buy
15,055
+55
+0.4% +$1.48K 0.18% 69
2018
Q4
$243K Hold
15,000
0.13% 87
2018
Q3
$311K Hold
15,000
0.14% 81
2018
Q2
$229K Buy
15,000
+14,989
+136,264% +$229K 0.11% 82
2018
Q1
$0 Buy
+11
New ﹤0.01% 717
2017
Q4
Sell
-140
Closed -$5K 650
2017
Q3
$5K Hold
140
﹤0.01% 348
2017
Q2
$4K Hold
140
﹤0.01% 363
2017
Q1
$5K Hold
140
﹤0.01% 397
2016
Q4
$4K Hold
140
﹤0.01% 440
2016
Q3
$4K Buy
+140
New +$4K ﹤0.01% 370